Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 5 Years
Incyte Q3 2024 Earnings Preview
Oppenheimer's One Buy Vs. One Sell Idea From Each SMID Sector
Here's How Much $100 Invested In Viking Therapeutics 5 Years Ago Would Be Worth Today
Sweetgreen, Tesla, Digital Realty Trust And A Health Care Stock On CNBC's 'Final Trades'
AbbVie to Buy Aliada Therapeutics for $1.4B in Cash
About 75% of Companies That Reported Earnings This Week Delivered EPS Wins-Earnings Scorecard
Forecasting The Future: 11 Analyst Projections For AbbVie
AbbVie Analyst Ratings
IDEAYA Reports Phase 1 Expansion Data for IDE397
Check Out What Whales Are Doing With ABBV
3 Health Care Stocks Moving In Thursday's Intraday Session
Peering Into Insmed's Recent Short Interest
UPS Posts Upbeat Q3 Results, Joins Tesla, Celestica, Pool, T-Mobile And Other Big Stocks Moving Higher On Thursday
Market-Moving News for October 24th
Viking Therapeutics Shares Are Trading Higher After the Company Reported Better-than-expected Q3 EPS Results.
Viking Therapeutics GAAP EPS of -$0.22 Beats by $0.03
$100 Invested In Alnylam Pharmaceuticals 15 Years Ago Would Be Worth This Much Today
Incyte Analyst Ratings
Here Are the Major Earnings After the Close Today